FERRIGNO, ILARIA
 Distribuzione geografica
Continente #
EU - Europa 281
NA - Nord America 241
AS - Asia 56
AF - Africa 3
OC - Oceania 1
SA - Sud America 1
Totale 583
Nazione #
US - Stati Uniti d'America 241
GB - Regno Unito 87
IE - Irlanda 68
IT - Italia 63
CN - Cina 26
SE - Svezia 26
FR - Francia 15
VN - Vietnam 15
UA - Ucraina 10
FI - Finlandia 5
TR - Turchia 5
DE - Germania 3
EG - Egitto 3
ID - Indonesia 3
BE - Belgio 2
IQ - Iraq 2
IR - Iran 2
AU - Australia 1
CL - Cile 1
HK - Hong Kong 1
JP - Giappone 1
NL - Olanda 1
PH - Filippine 1
RU - Federazione Russa 1
Totale 583
Città #
Southend 84
Dublin 67
Ashburn 40
Fairfield 37
Siena 25
Chandler 21
Ann Arbor 19
Woodbridge 19
Dong Ket 15
Seattle 11
Houston 10
Wilmington 9
Beijing 8
Cambridge 8
Jacksonville 8
Princeton 8
Dearborn 7
Florence 6
Cagliari 4
Helsinki 4
Izmir 4
Azzano Decimo 3
Banjarmasin 3
Milan 3
Nanjing 3
Rome 3
San Francisco 3
Shenyang 3
Boardman 2
Brussels 2
Giza 2
Guangzhou 2
Jinan 2
Messina 2
San Diego 2
San Mateo 2
Washington 2
Almere Stad 1
Andover 1
Cairo 1
Cerveteri 1
Chongqing 1
Duncan 1
Hefei 1
Hong Kong 1
Kashan 1
Kocaeli 1
Kunming 1
Lappeenranta 1
Leeds 1
London 1
Melbourne 1
Montecatini Terme 1
Nanchang 1
Nashville 1
New York 1
Norwalk 1
Phoenix 1
Redwood City 1
Shanghai 1
Tianjin 1
Tokyo 1
Torino 1
Totale 479
Nome #
Residual peripheral blood CD26+leukemic stem cells in chronic myeloid leukemia patients during TKI therapy and during treatment-free remission 191
Study of gene polymorphisms as predictors of treatment efficacy and toxicity in patients with indolent non-hodgkin lymphomas and mantle cell lymphoma receiving bendamustine and rituximab 166
Prospective evaluation of pro/anti-inflammatory cytokines during TKI treatment in chronic myeloid leukemia patients 77
Minimal residual disease in multiple myeloma: State of the art and applications in clinical practice 75
Pro-Inflammatory and Pro-Oxidative Changes During Nilotinib Treatment in CML Patients: Results of a Prospective Multicenter Front-Line TKIs Study (KIARO Study) 54
Prospective Monitoring of Peripheral Blood CD26+ Leukemia Stem Cells in Chronic Myeloid Leukemia Patients from Time of TKI Discontinuation 23
Validation of a double-color ELISpot assay of IFN-γ and IL-4 production in human peripheral blood mononuclear cells 19
Totale 605
Categoria #
all - tutte 2.322
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.322


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201947 0 0 0 0 0 0 0 0 0 0 22 25
2019/2020106 14 5 3 12 9 11 13 12 8 12 4 3
2020/2021122 6 2 5 12 10 7 11 14 10 20 5 20
2021/202270 2 8 2 3 11 2 1 4 2 5 14 16
2022/202399 5 13 15 15 6 20 1 10 4 2 6 2
2023/2024118 5 1 9 13 1 24 48 7 3 2 5 0
Totale 605